ArticleFrontiers in clinical diabetes and healthcare2026

Pemafibrate is associated with greater reductions in MDA-LDL and small dense LDL fractions with exploratory PBMC gene-expression changes: a prespecified subanalysis of the PARADISE in Kagoshima study.

Toru Kubo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.